Source - RNS
RNS Number : 4757R
Polo Resources Limited
14 June 2018
 

14  June 2018

 

 

 

Polo Resources Limited

 

("Polo" or the "Company")

 

 

CELAMIN HOLDINGS NL - INVESTMENT UPDATE

Polo Resources Limited (AIM: POL), the multi-sector investment company with interests in oil, gold, coal, copper, phosphate, lithium, iron and vanadium, notes that Australian Securities Exchange ("ASX") has released a notice reinstating Celamin Holdings NL ("Celamin") (ASX: CNL) to Official Quotation. The suspension of trading in the securities of Celamin will be lifted from the commencement of trading on Friday 15 June 2018, following the Celamin's lodgement of all outstanding financial reports and its demonstration to ASX of compliance with chapter 12 of the listing rules.

The full details of the announcement can be found at https://www.asx.com.au/asx/share-price-research/company/CNL.

 

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

 

For further information, please contact: 

  Polo Resources Limited

  - Kudzayi Denenga, Investor Relations

+27 (0) 787 312 919

 

 

  Allenby Capital Limited (Nominated adviser & joint broker)

  - John Depasquale

 

+44 (0)20 3328 5657

 

  Liberum Capital (Broker)

  - Henry Freeman

 

+44 (0) 20 3100 2000

 

  Blytheweigh (Public relations)

  - Tim Blythe, Nick Elwes, Camilla Horsfall

+44 (0) 207 138 3204 

 

 

 

 

 

About the Company

 

Polo Resources Limited is a multi-sector investment company focused on investing in undervalued companies and projects with strong fundamentals and attractive growth prospects. For complete details on Polo, please refer to: www.poloresources.com.

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCFMGMVVDGGRZM